Lonidamine, a New Approach to Cancer Therapy

Oncology ◽  
1984 ◽  
Vol 41 (1) ◽  
pp. 2-6 ◽  
Author(s):  
A. Caputo ◽  
B. Silvestrini
Keyword(s):  
Cancer Therapy ◽  
New Approach

scholarly journals Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy

PLoS ONE ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. e28321 ◽  
Author(s):  
Augusto Pessina ◽  
Arianna Bonomi ◽  
Valentina Coccè ◽  
Gloria Invernici ◽  
Stefania Navone ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
New Approach

scholarly journals Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin

Toxins ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 582 ◽  
Author(s):  
Bei Cheng ◽  
Peisheng Xu
Keyword(s):  
Cancer Therapy ◽  
Targeted Delivery ◽  
Cell Permeability ◽  
Peptide Drug ◽  
New Approach ◽  
The Poor ◽  
Poor Stability ◽  
Target Effects

Although peptide therapeutics have been explored for decades, the successful delivery of potent peptides in vitro and in vivo remains challenging due to the poor stability, low cell permeability, and off-target effects. We developed a redox sensitive polymer-based nanocomplex which can efficiently and stably deliver the peptide drug melittin for cancer therapy. The nanocomplex selectively targets cancer cells through lactobionic acid mediated endocytosis and releases melittin intracellularly upon the trigger of elevated redox potential. In vivo study proved that the targeted nanocomplex shows excellent potency in inhibiting tumor growth in a xenograft colon cancer mouse model. Thus, the polymer/melittin nanocomplexes will provide a new approach for melittin based cancer therapy.

An Artificial Lymph Gland: A New Approach to Cancer Therapy

1988 ◽  
Vol 12 (3) ◽  
pp. 243-247 ◽  
Author(s):  
A. A. Pineda ◽  
I. J. Sniecinski ◽  
H. C. Stevenson
Keyword(s):  
Cancer Therapy ◽  
Lymph Gland ◽  
New Approach

Cancer Therapy: A Possible New Approach

Science ◽  
1963 ◽  
Vol 140 (3574) ◽  
pp. 1391-1392 ◽  
Author(s):  
A. Szent-Gyorgyi ◽  
A. Hegyeli ◽  
J. A. McLaughlin
Keyword(s):  
Cancer Therapy ◽  
New Approach

Immunotoxins: A New Approach to Cancer Therapy

2019 ◽  
pp. 73-85 ◽  
Author(s):  
Ellen S. Vitetta ◽  
Keith A. Krolick ◽  
Muneo Miyama-Inaba ◽  
William Cushley ◽  
Jonathan W. Uhr
Keyword(s):  
Cancer Therapy ◽  
New Approach

Statins: a new approach to combat temozolomide chemoresistance in glioblastoma

2018 ◽  
Vol 66 (8) ◽  
pp. 1083-1087 ◽  
Author(s):  
Shahla Shojaei ◽  
Javad Alizadeh ◽  
James Thliveris ◽  
Navid Koleini ◽  
Elissavet Kardami ◽  
...  
Keyword(s):  
Cell Proliferation ◽  
Glioblastoma Multiforme ◽  
Cancer Therapy ◽  
Life Expectancy ◽  
Chemotherapeutic Agents ◽  
Average Life ◽  
Average Life Expectancy ◽  
New Approach ◽  
Anticancer Effects ◽  
Inhibit Cell Proliferation

Patients with glioblastoma multiforme (GBM) have an average life expectancy of approximately 15 months. Recently, statins have emerged as a potential adjuvant cancer therapy due to their ability to inhibit cell proliferation and induce apoptosis in many types of cancer. The exact mechanisms that mediate the inhibitory actions of statins in cancer cells are largely unknown. The purpose of this proceeding paper is to discuss some of the known anticancer effects of statins, while focusing on GBM therapy that includes adjunct therapy of statins with chemotherapeutic agents.

Immunotoxins: a new approach to cancer therapy

Science ◽  
1983 ◽  
Vol 219 (4585) ◽  
pp. 644-650 ◽  
Author(s):  
E. Vitetta ◽  
K. Krolick ◽  
M Miyama-Inaba ◽  
W Cushley ◽  
J. Uhr
Keyword(s):  
Cancer Therapy ◽  
New Approach

Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy

2002 ◽  
Vol 3 (12) ◽  
pp. 1739-1751 ◽  
Author(s):  
Gerald Batist ◽  
Jeremy Barton ◽  
Philip Chaikin ◽  
Christine Swenson ◽  
Lauri Welles
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Breast Cancer Therapy ◽  
New Approach
Sign in / Sign up

Export Citation Format

Share Document